Imbruvica, Drug to Treat Blood Cancer, Gains FDA Approval
Imbruvica will cost about $ 91 a pill, with four pills taken together once a day. That works out to about $ 10,900 a month, or more than $ 130,000 a year, in line with the recent trend of ever-increasing cancer drug prices. Robert W. Duggan, chief …
Read more on New York Times

Will The New Hepatitis C Drugs Trigger A Battle Over Cost?
As excitement mounts among physicians and investors over a new batch of drugs for treating hepatitis C, there is also concern that patients in developing countries may not have sufficient access due to high prices. But a recent poster presentation at a …
Read more on Forbes